The ability to custom synthesize a scale inhibitor product for any specific scaling regime would be extremely advantageous. This paper presents the results of an R&D initiative in developing such a product range. These polymeric scale inhibitors incorporate patented, phosphorus based monomer species utilizing end-capped technology that allows specific performance characteristics of the product to be altered. Presented within the paper are the results of the product development along with details of the laboratory testing undertaken to determine the performance envelope for these inhibitors.

You do not currently have access to this content.